You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 6, June 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Alzheimer Disease
 •Cognitive Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Biracial Population Study of Mortality in Mild Cognitive Impairment and Alzheimer Disease

Robert S. Wilson, PhD; Neelum T. Aggarwal, MD; Lisa L. Barnes, PhD; Julia L. Bienias, ScD; Carlos F. Mendes de Leon, PhD; Denis A. Evans, MD

Arch Neurol. 2009;66(6):767-772.

Objective  To assess mortality associated with mild cognitive impairment (MCI) and Alzheimer disease (AD) among older African Americans and whites from an urban community.

Design  Longitudinal population-based observational study.

Setting  Four adjacent neighborhoods in Chicago, Illinois.

Participants  Persons deemed free of dementia in a previous wave of data collection (n = 1715) underwent detailed clinical evaluation: 802 had no cognitive impairment (46.8%), 597 had MCI (34.8%), 296 had AD (17.3%), and 20 had other forms of dementia (1.2%).

Main Outcome Measure  All-cause mortality.

Results  During as many as 10 years of observation (mean [SD], 4.7 [3.0] years), 634 individuals died (37.0%). Compared with people without cognitive impairment, risk of death was increased by about 50% among those with MCI (hazard ratio [95% confidence interval], 1.48 [1.22-1.80]) and was nearly 3-fold greater among those with AD (2.84 [2.29-3.52]). These effects were seen among African Americans and whites and did not differ by race. Among participants with MCI, risk of death increased with more severe cognitive impairment, and this effect did not vary by race. A similar effect was seen among participants with AD, but it was slightly stronger for African Americans vs whites. In the MCI and AD groups, the association of cognitive impairment with survival was stronger for perceptual speed than for other cognitive functions.

Conclusion  The presence and severity of MCI and AD are associated with reduced survival among African Americans, and these effects are comparable to those seen among whites.


Author Affiliations: Rush Alzheimer's Disease Center (Drs Wilson, Aggarwal, and Barnes), Rush Institute for Healthy Aging (Drs Bienias, Mendes de Leon, and Evans), and Departments of Neurological Sciences (Drs Wilson, Aggarwal, Barnes, and Evans), Behavioral Sciences (Drs Wilson and Barnes), and Internal Medicine (Drs Bienias, Mendes de Leon, and Evans), Rush University Medical Center, Chicago, Illinois.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(6):689-690.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.